Some insurers in the ACA’s small group market are citing tariffs, particularly those affecting prescriptions drugs, as a reason for higher-than-expected premium increases.
Recent Posts
- Prestige Underwriting promotes Carl McComb to Underwriting & Pricing Director
- Davies to acquire Canada’s SCM Insurance Services
- Howden agrees to acquire Evelyn Partners Financial Services
- Gallagher Re hires RenRe’s Lowry as Exec Dir, Global Credit, Surety & Political Risk Product
- FutureProof Technologies to enhance wildfire coverage with Terrafuse AI acquisition